Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HCWB stock hub

HCW Biologics Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HCWBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

HCWB

In the news

Latest news · HCWB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC-103.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HCWB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

195

Groups with data

Currency

USD

Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001828673
Company name	HCW Biologics Inc.
Country	United States
Country code	US
Cusip	40423R204
Employees	36
Employees Change	-9%
Employees Change Percent	-20
Enterprise value	$7.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-07-20
Isin	US40423R2040
Last refreshed	2026-05-10
Market cap	$2.2M
Market cap category	Nano-Cap
Price	$0.33
Price currency	USD
Rev Per Employee	1,506.44x
Sector	Healthcare
Sic	2834
Symbol	HCWB
Website	https://www.hcwbiologics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1,007.4%
EV/Sales	130.37x
FCF yield	-605%
P/B ratio	0.39x
P/S ratio	40.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	20%
Gross Profit	$10,846
Gross Profit Growth	-98.87%
Gross Profit Growth Q	-93.16%
Gross Profit Growth3 Y	-83.87%
Gross Profit Growth5 Y	-69.49%
Net Income	$-22.3M
Net Income Growth Years	1%
Pretax Margin	-14,677.14%
Profit Per Employee	$-619,408
ROA	-31.19
Roa5y	-35.36
ROCE	-395.2
ROIC	-103.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-95.32%
Cagr3y	-82.29%
EPS Growth Quarters	6
EPS Growth Years	1
Revenue Growth	-97.89x
Revenue Growth Q	-93.16x
Revenue Growth Years	0x
Revenue Growth3 Y	-79.94x
Revenue Growth5 Y	-57.9x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$24.5M
Cash	$2M
Current Assets	$2.3M
Current Liabilities	$21.1M
Debt	$6.8M
Debt Equity	$2.46
Equity	$2.8M
Interest Coverage	-16.17
Liabilities	$21.8M
Long Term Assets	$22.2M
Long Term Liabilities	$692,531
Net Cash	$-4.9M
Net Cash By Market Cap	$-219
Net Debt Equity	$1.76
Tangible Book Value	$2.8M
Tangible Book Value Per Share	$0.84
WACC	9.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.11
Net Working Capital	$-13.9M
Quick ratio	0.09
Working Capital	$-18.8M
Working Capital Turnover	$-0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-116.3%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-95.31%
200-day SMA	2.27
3Y total return	-99.44%
50-day SMA	0.47
50-day SMA vs 200-day SMA	50under200
All Time High	311
All Time High Change	-99.89%
All Time High Date	2021-07-20
All Time Low	0.25
All Time Low Change	31.48%
All Time Low Date	2026-04-02
ATR	0.06
Beta	1.14
Beta1y	3.35
Beta2y	1.35
Ch YTD	-66.13
High	0.34
High52	17.8
High52 Date	2025-05-13
High52ch	-98.15%
Low	0.3
Low52	0.25
Low52 Date	2026-04-02
Low52ch	31.48%
Ma50ch	-30.21%
Premarket Change Percent	1.16
Premarket Price	$0.32
Premarket Volume	19,375
Price vs 200-day SMA	-85.5%
RSI	40.15
RSI Monthly	28.04
RSI Weekly	30.28
Sharpe ratio	-0.83x
Sortino ratio	-1.66
Total Return	-116.3%
Tr YTD	-66.13
Tr1m	20.4%
Tr1w	-27.28%
Tr3m	-68.39%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.44
Operating Income	$-13.7M
Operating margin	-25,192.7
Price target	$35
Price Target Change	$10,548

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,152,095%
Float Percent	91.36%
Net Borrowing	22,377
Shares Insiders	8.64%
Shares Institutions	1.99%
Shares Out	6,734,104
Shares Qo Q	49.73%
Shares Yo Y	116.3%
Short Float	2.12%
Short Ratio	0.01
Short Shares	1.94

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-14.2M
Average Volume	2,115,717.55x
Bv Per Share	0.84
Ch1m	20.4
Ch1w	-27.28
Ch1y	-95.31
Ch3m	-68.39
Ch3y	-99.44
Ch6m	-89.12
Change	2.62%
Change From Open	2.56
Close	0.32
Days Gap	0.06
Depreciation Amortization	1,041,771
Dollar Volume	89,471.2
Earnings Date	2026-05-15
Earnings Time	amc
EBIT	$-13.7M
EBITDA	$-12.6M
EPS	$-10.63
F Score	1
FCF	$-13.4M
FCF EV Yield	-189.41x
FCF Per Share	$-1.99
Financing CF	10,669,509
Fiscal Year End	December
Founded	2,018
Ipr	-95.89
Iprfo	-99.89
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Date	2025-04-11
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	1.58
Ma150ch	-79.14%
Ma20	0.4
Ma20ch	-17.06%
Net CF	-2,722,108
Next Earnings Date	2026-05-22
Open	0.32
Optionable	No
Position In Range	76.99
Post Close	0.33
Postmarket Change Percent	-2.34
Postmarket Price	$0.32
Ppne	20,880,849
Pre Close	0.32
Price Date	2026-05-08
Ptbv Ratio	0.8
Relative Volume	0.13x
Revenue	54,232x
SBC By Revenue	1,417.29x
Share Based Comp	768,623
Tr6m	-89.12%
Us State	Florida
Volume	272,197
Z Score	-8.67

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HCWB pay a dividend?

Capital-return profile for this ticker.

Performance

HCWB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HCWB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.0%

Float: +91.4% of shares outstanding

Insider ownership

+8.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

HCWB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.2

Neutral momentum band

Price vs 200-day MA

-85.5%

50/200-day relationship not available

Beta (5Y)

1.14

Moves roughly with the market

Sharpe ratio

-0.83

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HCWB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current HCWB stock rating?

HCW Biologics Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full HCWB analysis?

The full report lives at /stocks/HCWB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for HCWB?

The latest report frames HCWB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the HCWB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.